Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › peritoneal dialysis-associated peritonitis

Peritoneal dialysis-associated peritonitis

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for peritoneal dialysis-associated peritonitis

3 trials tracked for peritoneal dialysis-associated peritonitis.

3Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 1 1 Other / NA 2
  1. Phase 1 Vancomycin Pharmacokinetics in Patients on Peritoneal Dialysis Completed
  2. N/A Vancomycin Plus Moxifloxacin Versus Vancomycin Plus Ceftazidime for the Treatment of Peritoneal Dialysis (PD)-Related Peritonitis Completed
  3. N/A Prevention of Peritonitis in Peritoneal Dialysis Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Higher neutrophil-to-lymphocyte ratio linked to peritoneal dialysis peritonitis risk
Rheumatology Cohort
Higher neutrophil-to-lymphocyte ratio linked to peritoneal dialysis peritonitis risk Higher blood ratio linked to infection risk in peritoneal dialysis patients
This retrospective case-control study of 178 patients on peritoneal dialysis found that a higher neutrophil-to-lymphocyte ratio (NLR) was in…
A higher neutrophil-to-lymphocyte ratio in blood tests was linked to a greater risk of peritonitis in people on peritoneal dialysis.
Frontiers Apr 23, 2026